Experience Explosive Growth with Catent, Inc.: Second Quarter FY 2023 Earnings Conference Webcast

Catalent, Inc. (NYSE: CTLT) – the global leader in developing, launching and supplying better treatments for patients – will be releasing its financial results for the second quarter of fiscal year 2023 on Tuesday, February 7, 2023, prior to the market opening. Join the Company’s management on the same day at 8:15 a.m. ET to hear the latest results in a live webcast.

Access to a supplemental slide presentation, alongside a replay of the webcast, will be available for 90 days in the “Investors” section of Catalent’s website. Make sure to check out the presentation prior to the start of the webcast to get the full benefit of the event.

About Catalent, Inc.

Catalent is the global leader in enabling pharma, biotech, and consumer health partners to develop and supply the medicines and health products patients need, when they need them. With our deep expertise in development sciences, delivery technologies, and multi-modality manufacturing, we are a trusted partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Our flexible manufacturing platforms across 50 global sites provide around 80 billion doses of nearly 8,000 products annually, and our expert team of over 18,000 scientists and technicians help to accelerate over 1,000 partner programs and launch over 150 new products each year. This commitment has resulted in nearly $5 billion in revenue in our 2022 fiscal year. We strive to be the partners who help to make a difference in the lives of patients around the world.

Leave a Comment